Ankara

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Chronic rhinosinusitis with nasal polyps2 trials
• COPD1 trial
• Gastric and oesophageal cancer1 trial
• Lupus (SLE)1 trial

Phase

• Phase 23 trials
• Phase 33 trials

Status

• Active, not recruiting3 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Sanofi6 trials

Running trials

• Recruiting

  A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

  NCT07116031· Phase 2· Sanofi· Source

• Recruiting

  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  NCT07190209· Phase 3· Sanofi· Source

• Active, not recruiting

  A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

  NCT06834347· Phase 3· Sanofi· Source

• Active, not recruiting

  A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

  NCT06834360· Phase 3· Sanofi· Source

• Active, not recruiting

  Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

  NCT05039840· Phase 2· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Terminated

  Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer

  NCT05071053· Phase 2· Sanofi· Source